| Cloning and characterization of CAP, the S. cerevisiae gene encoding the 70 kd adenylyl cyclase-associated protein J Field, A Vojtek, R Ballester, G Bolger, J Colicelli, K Ferguson, J Gerst, ... Cell 61 (2), 319-327, 1990 | 312 | 1990 |
| Mutations of the ephrin-B1 gene cause craniofrontonasal syndrome I Wieland, S Jakubiczka, P Muschke, M Cohen, H Thiele, KL Gerlach, ... The American Journal of Human Genetics 74 (6), 1209-1215, 2004 | 269 | 2004 |
| A novel member of the NF2/ERM/4.1 superfamily with growth suppressing properties in lung cancer YK Tran, O Bögler, KM Gorse, I Wieland, MR Green, IF Newsham Cancer research 59 (1), 35-43, 1999 | 211 | 1999 |
| A method for difference cloning: gene amplification following subtractive hybridization. I Wieland, G Bolger, G Asouline, M Wigler Proceedings of the National Academy of Sciences 87 (7), 2720-2724, 1990 | 173 | 1990 |
| Microbeam MOMeNT: non-contact laser microdissection of membrane-mounted native tissue. M Böhm, I Wieland, K Schütze, H Rübben The American journal of pathology 151 (1), 63, 1997 | 167 | 1997 |
| Differences of E-cadherin expression levels and patterns in primary and metastatic human lung cancer M Böhm, B Totzeck, W Birchmeier, I Wieland Clinical & experimental metastasis 12, 55-62, 1994 | 108 | 1994 |
| Clinical and genetic aspects of craniofrontonasal syndrome: towards resolving a genetic paradox P Wieacker, I Wieland Molecular genetics and metabolism 86 (1-2), 110-116, 2005 | 82 | 2005 |
| Twenty‐six novel EFNB1 mutations in familial and sporadic craniofrontonasal syndrome (CFNS) I Wieland, W Reardon, S Jakubiczka, B Franco, W Kress, ... Human mutation 26 (2), 113-118, 2005 | 76 | 2005 |
| Isolation of DICE1: a gene frequently affected by LOH and downregulated in lung carcinomas I Wieland, KC Arden, D Michels, L Klein-Hitpass, M Böhm, CS Viars, ... Oncogene 18 (32), 4530-4537, 1999 | 68 | 1999 |
| Specific mosaic KRAS mutations affecting codon 146 cause oculoectodermal syndrome and encephalocraniocutaneous lipomatosis S Boppudi, N Bögershausen, HB Hove, EF Percin, D Aslan, R Dvorsky, ... Clinical genetics 90 (4), 334-342, 2016 | 63 | 2016 |
| Frequent allelic deletion at a novel locus on chromosome 5 in human lung cancer I Wieland, M Böhm Cancer research 54 (7), 1772-1774, 1994 | 62 | 1994 |
| Allelic deletion mapping on chromosome 5 in human carcinomas. I Wieland, M Böhm, KC Arden, T Ammermüller, S Bogatz, CS Viars, ... Oncogene 12 (1), 97-102, 1996 | 58 | 1996 |
| Refinement of the deletion in 7q21. 3 associated with split hand/foot malformation type 1 and Mondini dysplasia I Wieland, P Muschke, S Jakubiczka, M Volleth, B Freigang, PF Wieacker Journal of medical genetics 41 (5), e54-e54, 2004 | 54 | 2004 |
| Monoclonal antibodies NORM-1 and NORM-2 induce more normal behavior of tumor cells in vitro and reduce tumor growth in vivo HP Vollmers, BA Imhof, I Wieland, A Hiesel, W Birchmeier Cell 40 (3), 547-557, 1985 | 52 | 1985 |
| Clinical and Genetic Evaluation of Patients with KATP Channel Mutations from the German Registry for Congenital Hyperinsulinism K Mohnike, I Wieland, W Barthlen, S Vogelgesang, S Empting, W Mohnike, ... Hormone research in pædiatrics 81 (3), 156-168, 2014 | 50 | 2014 |
| Microsatellite instability and loss of heterozygosity at the hMLH1 locus on chromosome 3p21 occur in a subset of nonsmall cell lung carcinomas. I Wieland, T Ammermüller, M Böhm, B Totzeck, MF Rajewsky Oncology research 8 (1), 1-5, 1996 | 48 | 1996 |
| Contiguous gene deletions involving EFNB1, OPHN1, PJA1 and EDA in patients with craniofrontonasal syndrome I Wieland, C Weidner, R Ciccone, E Lapi, D McDonald‐McGinn, W Kress, ... Clinical genetics 72 (6), 506-516, 2007 | 46 | 2007 |
| Expansion of the phenotypic spectrum and description of molecular findings in a cohort of patients with oculocutaneous mosaic RASopathies OF Chacon‐Camacho, D Lopez‐Moreno, MA Morales‐Sanchez, ... Molecular Genetics & Genomic Medicine 7 (5), e625, 2019 | 45 | 2019 |
| Deletion analysis at the DEL‐27, APC and MTS1 loci in bladder cancer: LOH at the DEL‐27 locus on 5p13‐12 is a prognostic marker of tumor progression M Böhm, H Kirch, T Otto, H Rübben, I Wieland International journal of cancer 74 (3), 291-295, 1997 | 43 | 1997 |
| Dissecting the molecular mechanisms in craniofrontonasal syndrome: differential mRNA expression of mutant EFNB1 and the cellular mosaic I Wieland, R Makarov, W Reardon, S Tinschert, A Goldenberg, P Thierry, ... European journal of human genetics 16 (2), 184-191, 2008 | 42 | 2008 |
